Oral Dissolving Strip Stability: What Protects Shelf Life

Oral Dissolving Strip Stability: What Protects Shelf Life

▶ Watch the video breakdown

By Jack Zheng, MS Pharmacy — Founder of MIHIYO Labs

Summary

An oral dissolving strip (ODS) stays stable mainly because its formulation and packaging control residual moisture, not because film is inherently more shelf-stable. Published reviews of commercial orodispersible films report residual moisture content typically in the 3 to 6 percent range; above that band, higher water content raises the risk of active-ingredient recrystallization and microbial growth. That is why moisture-sensitive ODS products often use high-barrier unit-dose packaging, such as foil sachets or blister systems with desiccants. By contrast, a 2023 JAMA analysis found 88 percent of tested melatonin gummies were inaccurately labeled, a quality-control signal among those products. MIHIYO Labs formulates and packages its strips around that principle.

What actually protects an oral dissolving strip's shelf life?

The short answer is moisture control, not the polymer itself. An HPMC or pullulan film is not naturally more chemically stable than a tablet or a gummy — it is simply thinner and has more surface area exposed to air, which makes water management the dominant variable.4 Get the residual water content and the packaging barrier right, and proper moisture control paired with real barrier packaging is what gives a film a realistic chance of maintaining labeled potency through its intended shelf life. Get either wrong, and a film can lose its intended performance quickly, because it has so little mass to buffer moisture change. When I set packaging specs for MIHIYO's strips, moisture is the first variable I check, before taste or tensile strength, because it is the one variable that silently determines whether the dose is designed to remain consistent from manufacturing through the intended shelf-life period.

Why moisture, not time, is the real threat to a film's stability

Every polymer film formulation carries some water by design. Water can act as a plasticizer — it keeps the film flexible enough to fold and dissolve quickly instead of turning brittle. Residual moisture has to be controlled within a formulation-specific range: too little water and the film turns brittle; too much, and the same water increases plasticization, microbial risk, and the chance that an active pharmaceutical ingredient dissolved or suspended in the polymer matrix recrystallizes out. Published reviews of commercial orodispersible films report residual moisture content typically falling in the 3 to 6 percent range, with higher moisture linked to sticky films, slower disintegration, and elevated microbial-growth risk.2

Polymer choice affects how fast that moisture problem shows up. In a comparative study of pharmaceutical film formers, HPMC absorbed and retained less environmental moisture than gelatin or pullulan, with a higher critical relative humidity before uptake accelerated — one reason HPMC is a common backbone for oral films and capsules alike.1 That property does not eliminate the need for a moisture barrier; it buys formulation margin, not a substitute for one.

Oxidative degradation compounds the problem for moisture-sensitive actives. In one formulation study of an oxidation-sensitive drug in an orodispersible film, researchers evaluated antioxidant strategies — sodium metabisulfite, paired with a chelating synergist like EDTA to bind trace metal catalysts from the excipients — to improve chemical stability during formulation development.5 The lesson generalizes: an ODS formulation has to solve for moisture uptake and oxidation together, because either one alone can shorten shelf life independent of the other.

How moisture control determines oral dissolving strip stability Ambient humidity is blocked by a foil sachet and desiccant packaging barrier, keeping residual water in a film within the published 3 to 6 percent target range; moisture above that range raises the risk of active-ingredient recrystallization and microbial growth, while moisture within range keeps the strip flexible, fast-dissolving, and stable. Ambient humidity Outside the sealed package Foil sachet + desiccant Blocks moisture ingress Film interior, residual water Target: 3 to 6 percent Moisture above range Recrystallization, microbial risk Moisture within range Flexible, fast-dissolving, stable dose Based on residual-moisture ranges reported in published orodispersible film reviews

How does ODS stability compare with gummies and powders, in the data?

ICH-style stability testing gives drug products a shared yardstick, and the same conditions are useful for comparing how different dosage forms respond to stress. Under ICH Q1A(R2), long-term storage is tested at 25°C/60% relative humidity or 30°C/65% RH, and accelerated conditions run at 40°C/75% RH — deliberately harsh conditions meant to surface a formulation's weak points months before real-world aging would.7 A film, a gummy, and a capsule are all measured against that same accelerated stress, but they do not respond the same way.

Dimension Oral dissolving strip (ODS) Gummy Powder sachet
Primary degradation driver Moisture ingress into a thin, high-surface-area matrix2 Moisture migration within a hydrated gelatin/pectin gel9 Moisture ingress if the seal or barrier fails; lower risk when unopened in a high-barrier sachet
Packaging requirement High-barrier unit-dose format: foil sachet, aluminum laminate, or blister with desiccant, for sensitive actives4 Bottle or multi-dose pouch; less airtight per unit once opened Foil or laminate sachet, single-use
Demonstrated degradation example Oxidation-sensitive actives may need antioxidant strategies developed during formulation5 Unencapsulated vitamin C in a gummy matrix retained 79% of label after 10 weeks of accelerated aging, versus 92% when microencapsulated9 Fewer public accelerated-stability datasets on sachet-format actives
Independent label-accuracy signal No published market survey specific to ODS supplements yet 2023 JAMA analysis: 88% of 25 melatonin gummy brands inaccurately labeled, content 74–347% of claim8 Not separately surveyed

The gummy data point is a useful illustration. A gummy is a hydrogel — it is manufactured wet and stays wet, which is convenient for mouthfeel and unforgiving for a moisture-sensitive vitamin. In the casein-gel encapsulation study above, plain vitamin C mixed directly into gummy syrup lost roughly a fifth of its potency within ten weeks under accelerated conditions, while the same vitamin protected inside a microcapsule lost less than a tenth.9 The JAMA melatonin-gummy survey is a separate signal worth reading carefully: it demonstrates that measured content diverged sharply from the label across most tested brands, but the study was not designed to isolate the cause — formulation error, manufacturing variance, deliberate overage, or degradation over time could each contribute, and the paper does not attribute the gap to any one of them.8 Melatonin itself does show a documented degradation pathway under heat: kinetic studies in aqueous solution show melatonin degradation follows first-order kinetics and accelerates sharply with temperature, with degradation roughly six times faster at 90°C than at 60°C.10 Whether that pathway explains any specific gummy result is not something the label-accuracy data alone can answer.

Three published measures of moisture-driven instability in gummy dosage forms Encapsulated vitamin C in a gummy matrix retained 92 percent of label after 10 weeks of accelerated aging, versus 79 percent when unencapsulated; separately, only 12 percent of tested melatonin gummy brands fell within 10 percent of their labeled dose in a 2023 JAMA analysis. 0% 50% 100% Vitamin C, encapsulated in gummy matrix, 10-wk test 92% Vitamin C, unencapsulated same gummy matrix, 10-wk test 79% Melatonin gummy brands within 10% of labeled dose 12% Vitamin C data: Yan et al., 2021, Food Hydrocolloids (accelerated aging test). Label-accuracy data: Cohen et al., 2023, JAMA (3 of 25 gummy brands tested).

What this means for MIHIYO's formulation and packaging choices

The studies above were run on the molecules and film platforms in research and industry settings — not on MIHIYO's own strips — and I want to be direct about that distinction before drawing the connection. What they establish is the mechanism, and the mechanism is what I design against.

Every MIHIYO strip ships in an individual foil sachet, not a shared bottle, which limits each dose's moisture exposure to a single opening event rather than repeated exposure every time a bottle is unscrewed. That single-dose foil format is the same packaging logic that formulation reviews of orodispersible films point to for moisture-sensitive actives — aluminum pouches and barrier films are the standard because the film's high surface-to-mass ratio leaves it with little buffer against ambient humidity.4 For the Sleep-Support strip, that matters directly: melatonin's documented heat-driven degradation pathway makes moisture-barrier packaging a formulation-control choice, not a cosmetic one. Confirming labeled-dose accuracy across the product's full shelf life still requires finished-product stability testing, which is the ICH-style dataset flagged as not yet public further below.10

For Mood-Boost, 5-HTP has been studied directly in a compounded orodispersible film vehicle at a 50 mg per-film dose comparable to what MIHIYO uses, alongside melatonin, vitamin D3, and vitamin B12 in the same compatibility work.3 Caffeine is a separate case: rather than lean on that same compatibility study, which did not test caffeine, the relevant support for Energy-Focus comes from dedicated caffeine orodispersible film research — HPMC-based caffeine films have been formulated and characterized directly, independent of the 5-HTP and melatonin compatibility work above.6 The formulation trade-off I keep coming back to is thickness versus dissolve time: a thicker film can carry more desiccant-adjacent excipient headroom and dry down further, but past a certain point it stops dissolving in the 30-to-60-second window that makes an ODS behave like a fast-dissolving oral format rather than a slow-disintegrating swallowed tablet. Related: see how HPMC and pullulan film-forming polymers are chosen for the upstream formulation decisions that set this stability baseline before packaging ever enters the picture.

Where the stability argument falls short

A foil sachet is not a substitute for correct formulation, and it is worth saying plainly that packaging alone cannot rescue a poorly designed film. If the antioxidant system is wrong for a given active, or the polymer blend traps more residual moisture than the formulation's target range, the strip will still degrade inside good packaging — just more slowly than it otherwise would.

I also want to flag what is not yet public: MIHIYO has not published its own accelerated or long-term ICH-style stability dataset for third-party review. The formulation choices described here follow the same principles the cited studies establish for orodispersible films generally, but "follows established principles" is not the same claim as "has published stability data specific to this product," and readers should treat that gap honestly rather than assume equivalence. Once opened, a foil sachet's protection ends — an ODS strip left unwrapped on a counter in a humid room will absorb moisture and degrade faster than the same strip left sealed, same as any other film-based product. And no packaging format changes the underlying chemistry of a given active; if a molecule is inherently unstable at room temperature regardless of vehicle, film format alone will not fix that.

The bottom line

Oral dissolving strip stability and shelf life come down to two variables the pharmacology already predicts: how much water the film formulation is designed to hold, and how well the packaging keeps additional moisture out between manufacture and use. Keep residual moisture within the formulation's target range — published reviews put commercial orodispersible films around 3 to 6 percent — pair it with the right antioxidant system for the active involved, and seal it in a foil sachet. Proper moisture control and barrier packaging can help maintain potency without the same hydrated-matrix stability challenges shown in gummy vitamin data, though that is a formulation goal to design toward, not a guarantee any given film automatically achieves. MIHIYO Labs builds every strip's packaging around that principle first, because a precise dose that degrades unpredictably on the shelf is not actually a precise dose by the time it reaches you.

References

  1. Yang N, Chen H, Jin Z, Hou J, Zhang Y, Han H, Shen Y, Guo S. Moisture sorption and desorption properties of gelatin, HPMC and pullulan hard capsules. International Journal of Biological Macromolecules. 2020;159:659-666. DOI: 10.1016/j.ijbiomac.2020.05.110. https://www.sciencedirect.com/science/article/abs/pii/S0141813020332621
  2. Ferlak J, Guzenda W, Osmałek T. Orodispersible Films—Current State of the Art, Limitations, Advances and Future Perspectives. Pharmaceutics. 2023;15(2):361. PMID: 36839683. DOI: 10.3390/pharmaceutics15020361. https://pmc.ncbi.nlm.nih.gov/articles/PMC9965071/
  3. Polonini HC, Ferreira AO, Raposo NRB, da Silva PJLC, Brandão MAF. Compatibility Assessment of Novel Orodispersible Film Vehicle for Personalized Medicine with Selected Active Pharmaceutical Ingredients. Journal of Personalized Medicine. 2023;13(11):1565. PMID: 38003880. DOI: 10.3390/jpm13111565. https://pmc.ncbi.nlm.nih.gov/articles/PMC10672364/
  4. Jacob S, Boddu SHS, Bhandare R, Ahmad SS, Nair AB. Orodispersible Films: Current Innovations and Emerging Trends. Pharmaceutics. 2023;15(12):2753. PMID: 38140094. DOI: 10.3390/pharmaceutics15122753. https://pmc.ncbi.nlm.nih.gov/articles/PMC10747242/
  5. Çakmakyapan Ö, Tuğcu Demiröz FN, Teksin ZŞ. Preliminary Study on the Development of Orodispersible Film Containing Desloratadine. Turkish Journal of Pharmaceutical Sciences. 2025;22(1):55-63. PMID: 40052381. DOI: 10.4274/tjps.galenos.2024.46116. https://pmc.ncbi.nlm.nih.gov/articles/PMC11887595/
  6. Vlad RA, Pintea A, Coaicea M, Antonoaea P, Rédai EM, Todoran N, Ciurba A. Preparation and Evaluation of Caffeine Orodispersible Films: The Influence of Hydrotropic Substances and Film-Forming Agent Concentration on Film Properties. Polymers. 2023;15(9):2034. PMID: 37177181. DOI: 10.3390/polym15092034. https://pmc.ncbi.nlm.nih.gov/articles/PMC10181256/
  7. International Council for Harmonisation. Q1A(R2): Stability Testing of New Drug Substances and Products. ICH, 2003. https://www.ema.europa.eu/en/ich-q1a-r2-stability-testing-new-drug-substances-drug-products-scientific-guideline
  8. Cohen PA, Wen A, Gerona RR. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. JAMA. 2023;329(16):1401-1402. PMID: 37097362. https://jamanetwork.com/journals/jama/fullarticle/2804077
  9. Yan B, Davachi SM, Ravanfar R, Dadmohammadi Y, Deisenroth TW, Pho TV, Odorisio PA, Darji RH, Abbaspourrad A. Improvement of vitamin C stability in vitamin gummies by encapsulation in casein gel. Food Hydrocolloids. 2021;113:106414. https://www.sciencedirect.com/science/article/abs/pii/S0268005X20313886
  10. Pranil T, Moongngarm A, Loypimai P. Influence of pH, temperature, and light on the stability of melatonin in aqueous solutions and fruit juices. Heliyon. 2020;6(3):e03648. PMID: 32258489. DOI: 10.1016/j.heliyon.2020.e03648. https://pmc.ncbi.nlm.nih.gov/articles/PMC7109460/

By — Founder of MIHIYO Labs. Focused on the R&D of high-bioavailability, fast-absorption oral dissolving strips.

0 comments

Leave a comment

Please note, comments need to be approved before they are published.